Published in Clin Appl Thromb Hemost on December 15, 2010
Cerebral dissecting aneurysms in patients with essential thrombocythemia. J Korean Neurosurg Soc (2014) 0.75
Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology (2004) 3.43
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol (1987) 2.42
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
PTEN mutations in gliomas and glioneuronal tumors. Oncogene (1998) 2.01
Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol (2007) 1.84
Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL. Neurology (2007) 1.70
An arteriographic study of mesenteric arterial disease. I. Large vessel changes. Gut (1967) 1.52
[Utilization of pacifiers: distribution, causes and sequelae]. Schweiz Rundsch Med Prax (1993) 1.39
Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep (2000) 1.37
Forearm glucose uptake during the oral glucose tolerance test in normal subjects. Diabetes (1973) 1.34
Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28
Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation (2004) 1.27
Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr (1995) 1.26
Circulating immune complexes in a patient with meningococcal disease. Br Med J (1976) 1.23
Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative. Oncogene (2001) 1.22
The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase. J Biol Chem (1999) 1.22
The Causative Classification of Stroke system: an international reliability and optimization study. Neurology (2010) 1.19
Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia (2009) 1.18
Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology (2004) 1.17
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis. Oncogene (2010) 1.16
p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene (2001) 1.16
Identification of PP2A as a crucial regulator of the NF-kappaB feedback loop: its inhibition by UVB turns NF-kappaB into a pro-apoptotic factor. Cell Death Differ (2008) 1.12
Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology (2001) 1.12
Exocrine and endocrine pancreatic function in diabetes mellitus and chronic pancreatitis. Gut (1966) 1.11
Chemodectoma of the head and neck: results of treatment in 84 patients. Int J Radiat Oncol Biol Phys (1992) 1.08
Reduced cerebrovascular CO(2) reactivity in CADASIL: A transcranial Doppler sonography study. Stroke (2001) 1.04
Noncontrast CT in deep cerebral venous thrombosis and sinus thrombosis: comparison of its diagnostic value for both entities. AJNR Am J Neuroradiol (2009) 1.02
Familial hyperparathyroidism. Postgrad Med J (1966) 1.00
Parkin interacts with the proteasome subunit alpha4. FEBS Lett (2005) 0.99
Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology (2000) 0.97
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study. Ann Oncol (2005) 0.97
Dynamic expression of Drosophila TRAF1 during embryogenesis and larval development. Mech Dev (2001) 0.97
High-resolution black-blood contrast-enhanced T1 weighted images for the diagnosis and follow-up of intracranial arteritis. Br J Radiol (2010) 0.97
Retinal vascular abnormalities in CADASIL. Neurology (2004) 0.97
A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes. Brain Pathol (1998) 0.96
Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting. AJNR Am J Neuroradiol (2008) 0.95
MRI plaque imaging reveals high-risk carotid plaques especially in diabetic patients irrespective of the degree of stenosis. BMC Med Imaging (2010) 0.95
Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL. Acta Neuropathol (2001) 0.94
The pathogenesis of CADASIL: an update. J Neurol Sci (2004) 0.94
Cerebral angiitis in four patients with chronic GVHD. Bone Marrow Transplant (2009) 0.92
Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol (1999) 0.92
Apathy: a major symptom in CADASIL. Neurology (2009) 0.92
Cardiopulmonary exercise testing provides a predictive tool for early and late outcomes in abdominal aortic aneurysm patients. Ann R Coll Surg Engl (2011) 0.91
EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. Second of two parts. Eur J Neurol (2001) 0.91
[Advances in the diagnostics of Alzheimer's disease]. Nervenarzt (2012) 0.90
Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology (2006) 0.90
CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand (1997) 0.90
Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology (2007) 0.89
CTA for screening of complicated atherosclerotic carotid plaque--American Heart Association type VI lesions as defined by MRI. AJNR Am J Neuroradiol (2013) 0.89
Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol (1999) 0.89
Intracerebral haemorrhage in CADASIL. J Neurol Neurosurg Psychiatry (2005) 0.89
Genomic sequences of aldolase C (Zebrin II) direct lacZ expression exclusively in non-neuronal cells of transgenic mice. Proc Natl Acad Sci U S A (1998) 0.88
Parkin modulates gene expression in control and ceramide-treated PC12 cells. Mol Biol Rep (2006) 0.88
Giant cell arteritis of the Basal cerebral arteries: correlation of MRI, dsa, and histopathology. Neurology (2010) 0.87
A genome-wide survey of human short-term memory. Mol Psychiatry (2009) 0.87
Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology (2005) 0.86
Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis. Eur J Biochem (1999) 0.86
Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappaB-mediated downregulation of xIAP. Oncogene (2008) 0.86
EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. First of two parts. Eur J Neurol (2001) 0.85
Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases? Cephalalgia (2011) 0.84
RLS3: fine-mapping of an autosomal dominant locus in a family with intrafamilial heterogeneity. Neurology (2006) 0.84
Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study. Neurology (2001) 0.83
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: decrease in regional cerebral blood volume in hyperintense subcortical lesions inversely correlates with disability and cognitive performance. AJNR Am J Neuroradiol (2001) 0.83
Inherited Myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann Neurol (2001) 0.82
Familial hemiplegic migraine with cerebellar ataxia and paroxysmal psychosis. Eur Neurol (1999) 0.82
Improved carotid atherosclerotic plaques imaging with contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc (2011) 0.82
[Genetics of migraine]. Nervenarzt (2006) 0.82
Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34. Gene (1997) 0.81
Reversible cerebral vasoconstriction syndrome associated with hormone therapy for intrauterine insemination. Cephalalgia (2010) 0.81
Peripheral nerve and skeletal muscle involvement in CADASIL. Acta Neuropathol (2005) 0.81
Cerebral venous thrombosis: correlation between recanalization and clinical outcome--a long-term follow-up of 40 patients. J Neurol (2002) 0.81
Angiographic complications in CADASIL. Lancet (1997) 0.80
18F-fluoroethylcholine uptake in arterial vessel walls and cardiovascular risk factors: correlation in a PET-CT study. Nuklearmedizin (2010) 0.80
Motor cortex excitability in patients with migraine with aura and hemiplegic migraine. Cephalalgia (2000) 0.80
Anxiety, type A personality and endocrine responses to surgery. Br J Clin Psychol (1989) 0.80
Apathy is related to cortex morphology in CADASIL. A sulcal-based morphometry study. Neurology (2011) 0.80
Feasibility and reproducibility of the PsAMRIS-H score for psoriatic arthritis in low-field-strength dedicated extremity magnetic resonance imaging. Scand J Rheumatol (2013) 0.79
Decreased T1 contrast between gray matter and normal-appearing white matter in CADASIL. AJNR Am J Neuroradiol (2013) 0.79
Biological significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukemia. Br J Haematol (1991) 0.79
Verbal memory impairment in subcortical ischemic vascular disease: a descriptive analysis in CADASIL. Neurobiol Aging (2010) 0.79
The D2 receptor NcoI allele: absence of allelic association with migraine with aura. Neurology (1998) 0.79
Expansion of the phenotypic spectrum of the CACNA1A T666M mutation: a family with familial hemiplegic migraine type 1, cerebellar atrophy and mental retardation. Cephalalgia (2008) 0.79
[PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA)]. Rofo (2004) 0.78
[Treatment and late results of 33 fractures of the pilon tibialis (author's transl)]. Unfallchirurgie (1980) 0.78
IL-10 promotes secretion of S100A8/A9 from human monocytes trough an inclusion in plasma membranes. Scand J Immunol (2013) 0.78
A magnetic resonance imaging study of the cervical cord of patients with CADASIL. Neurology (2001) 0.78
Successful bilateral pallidal stimulation for Meige syndrome and spasmodic torticollis. Neurology (2006) 0.78
A novel mutation in CACNA1A associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline. J Neurol Sci (2010) 0.77
Peripheral glucose utilization in young men with myocardial infarction. Clin Sci (1970) 0.77
Dietary diabetes. The influence of a low carbohydrate diet on forearm metabolism in man. Diabetes (1973) 0.77
Ventricular arrhythmias complicating weight reduction therapy in a patient with a prolonged QT interval. Postgrad Med J (1985) 0.77
Malignant hemispheric infarction in Takayasu arteritis. J Neurol (2008) 0.77